Stoke Therapeutics, Inc. (STOK)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch STOK
See up to 3 months of STOK. The 7-day demo opens the 1M and 3M ranges and puts STOK on your watchlist.
Start 7-day demoLatest STOK insider trades
Jonathan Allan - OfficerOpen-market sale$17K- Barry Ticho - OfficerOpen-market sale
About Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. is an SEC registrant, filing under CIK 0001623526, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
STOK Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 12 | 34,594 | $1.07M |
| Grant or award | 2 | 264,674 | |
| Option exercise | 6 | 84,500 | |
STOK insider transactions (Form 4)
7988 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jonathan Allan - Officer | Open-market sale | Common Stock | 627 | $26.33 | $17K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 1,051 | $26.16 footnote F2 | $27K | |
| ||||||
| Alexander Cumbo - Director | Grant or award | Director Stock Option (Right to Buy) | 39,674 | $0.00 | - | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 3,945 | $30.51 footnote F2 | $120K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 1,600 | $31.06 footnote F3 | $50K | |
| ||||||
| Barry Ticho - Officer | Option exercise | Common Stock | 10,000 | $0.00 | - | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 4,525 | $32.01 footnote F2 | $145K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 242 | $32.47 footnote F3 | $8K | |
| Barry Ticho - Officer | Option exercise | Performance Stock Units | 10,000 | $0.00 | - | |
| ||||||
 Edward M. Md Kaye - Director | Option exercise | Common Stock | 26,250 | $0.00 | - | |
| Edward M. Md Kaye - Director | Open-market sale | Common Stock | 11,930 | $32.01 footnote F2 | $382K | |
| Edward M. Md Kaye - Director | Open-market sale | Common Stock | 637 | $32.47 footnote F3 | $21K | |
| Edward M. Md Kaye - Director | Option exercise | Performance Stock Units | 26,250 | $0.00 | - | |
| ||||||
| Jonathan Allan - Officer | Option exercise | Common Stock | 6,000 | $0.00 | - | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 2,716 | $32.01 footnote F2 | $87K | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 145 | $32.47 footnote F3 | $5K | |
| Jonathan Allan - Officer | Option exercise | Performance Stock Units | 6,000 | $0.00 | - | |
| ||||||
| Barry Ticho - Officer | Open-market sale | Common Stock | 5,907 | $28.95 footnote F2 | $171K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 1,269 | $29.45 footnote F3 | $37K | |
| ||||||
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 29,555 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 14,777 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 14,777 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 29,555 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 11,650 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 11,650 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 19,441 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 19,441 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 7,639 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 7,639 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 29,747 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 29,747 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
| Seth Loring Harrison | Gift | Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
 Thomas McCauley - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 6,728 | $32.62 footnote F2 | $219K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 500 | $33.27 footnote F3 | $17K | |
| ||||||
| Jonathan Allan - Officer | Open-market sale | Common Stock | 1,457 | $29.95 | $44K | |
| Arthur Tzianabos | Grant or award | Director Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
| Julie Smith | Grant or award | Director Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
 Arthur A. Levin | Grant or award | Director Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
| Adrian R. Krainer | Grant or award | Director Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
| Edward M. Md Kaye | Grant or award | Director Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
| Seth Loring Harrison | Grant or award | Director Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
| Jennifer Burstein | Grant or award | Director Stock Option (Right to Buy) | 17,786 | $0.00 | - | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 1,795 | $30.58 | $55K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 2,243 | $32.79 | $74K | |
| Clare Kahn | Grant or award | Stock Option (Right to Buy) | 30,782 | $0.00 | - | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 1,838 | $32.66 | $60K | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 8,692 | $33.64 footnote F2 | $292K | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 601 | $34.41 footnote F3 | $21K | |
| ||||||
| Barry Ticho - Officer | Open-market sale | Common Stock | 3,577 | $32.74 footnote F2 | $117K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 2,587 | $33.38 footnote F3 | $86K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 6,100 | $31.28 footnote F4 | $191K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 483 | $31.79 footnote F5 | $15K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 103 | $32.85 | $3K | |
| Barry Ticho - Officer | Option exercise | Common Stock | 1,365 | $2.19 | $3K | |
| Barry Ticho - Officer | Open-market sale | Common Stock | 1,461 | $29.99 | $44K | |
| Barry Ticho - Officer | Option exercise | Stock Option (Right to Buy) | 1,365 | $0.00 | - | |
| ||||||
 Thomas Leggett - Officer | Open-market sale | Common Stock | 2,173 | $31.28 footnote F4 | $68K | |
| Thomas Leggett - Officer | Open-market sale | Common Stock | 172 | $31.79 footnote F5 | $5K | |
| Thomas Leggett - Officer | Open-market sale | Common Stock | 37 | $32.85 | $1K | |
| Thomas Leggett - Officer | Open-market sale | Common Stock | 1,274 | $32.74 footnote F2 | $42K | |
| Thomas Leggett - Officer | Open-market sale | Common Stock | 922 | $33.38 footnote F3 | $31K | |
| ||||||
 Jason Hoitt - Officer | Open-market sale | Common Stock | 1,033 | $32.74 footnote F2 | $34K | |
| Jason Hoitt - Officer | Open-market sale | Common Stock | 748 | $33.38 footnote F3 | $25K | |
| Jason Hoitt - Officer | Open-market sale | Common Stock | 1,762 | $31.28 footnote F4 | $55K | |
| Jason Hoitt - Officer | Open-market sale | Common Stock | 139 | $31.79 footnote F5 | $4K | |
| Jason Hoitt - Officer | Open-market sale | Common Stock | 30 | $32.85 | $986 | |
| ||||||
| Jonathan Allan - Officer | Open-market sale | Common Stock | 4,222 | $31.28 footnote F4 | $132K | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 334 | $31.79 footnote F5 | $11K | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 72 | $32.85 | $2K | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 2,476 | $32.74 footnote F2 | $81K | |
| Jonathan Allan - Officer | Open-market sale | Common Stock | 1,791 | $33.38 footnote F3 | $60K | |
| ||||||
| Jason Hoitt - Officer | Option exercise | Common Stock | 10,000 | $0.00 | - | |
| Jason Hoitt - Officer | Option exercise | Restricted Stock Units | 10,000 | $0.00 | - | |
| Thomas Leggett - Officer | Option exercise | Common Stock | 14,750 | $0.00 | - | |
| Thomas Leggett - Officer | Option exercise | Restricted Stock Units | 14,750 | $0.00 | - | |
Item 5.02
Item 8.01, 9.01
Item 2.02, 9.01
Item 7.01, 8.01, 9.01
Recent STOK Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JONATHAN D ALLAN | Officer | 627 | $16K | View on EDGAR | |
| BARUCH TICHO | Officer | 20,967 |
STOK insider trading FAQ
What is the latest insider trade for STOK?
Stoke Therapeutics, Inc. (STOK) had 10 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for STOK runs to 88 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STOK stock?
No insider purchases of STOK were filed in the last 90 days.
How many insiders are selling STOK stock?
12 insider sales of STOK were filed in the last 90 days, totaling $1.07M.
Where can I see STOK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STOK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jonathan Allan view on EDGAR
- - Barry Ticho view on EDGAR
- - Alexander Cumbo view on EDGAR
- - Barry Ticho view on EDGAR
- - Barry Ticho view on EDGAR
- - Edward M. Md Kaye view on EDGAR
- - Jonathan Allan view on EDGAR
- - Barry Ticho view on EDGAR
- - Seth Loring Harrison view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where STOK's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow STOK with a 7-day demo
- STOK on your watchlist
- Every STOK Form 4 filing on record
- Up to 3 months of STOK price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
